Adjusting for patient selection suggests and addition of docetaxel to 5-fluorouracilcisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck
収録刊行物
-
- Anticancer Drugs
-
Anticancer Drugs 15 331-340, 2004